Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
The successful phase 3 niraparib ENGOTOVl 6/NOVA trial included a substantial number of patients with platinum resistant ovarian cancer (OC).
The successful phase 3 niraparib ENGOTOVl 6/NOVA trial included a substantial number of patients with platinum resistant ovarian cancer (OC). Del Campo, J., Mirza, M., Berek, J. S., Provencher, D. M., Emons, G., Fabbro, M., Lord, R., Colombo, N., Petru, E., Wenham, R., Herrstedt, J., Gilbert, L., Heubner, M., Martin, A., Follana, P., Benigno, B. B., Dorum, A., Rimel, B. J., Hazard, S., Matulonis, U. A. AMER SOC CLINICAL ONCOLOGY. 2017View details for DOI 10.1200/JCO.2017.35.15_suppl.5560
View details for Web of Science ID 000411931704038